Epitalon
Also known as: AEDG, AEDG peptide, Ala-Glu-Asp-Gly, Epithalamin analog, Epithalon, Epithalone
Source Epitalon at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Affiliate link: we earn a commission on purchases made through this link, at no extra cost to you.
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Epitalon is a synthetic tetrapeptide (Ala‑Glu‑Asp‑Gly) derived from pineal‑gland extracts and studied as a research compound for geroprotective, neuroendocrine, and retinal applications. Researchers investigate its ability to influence aging‑related pathways, boost melatonin production, support immune function, and protect retinal cells.
Mechanism of Action
Epitalon is reported to act primarily at the transcriptional level, altering expression of genes involved in melatonin synthesis, cytokines (CCL11, HMGB1), interleukin‑2, and telomerase. It may enhance antioxidant defenses, modulate neuro‑protective signaling, and stimulate enzymes such as acetylcholinesterase and butyrylcholinesterase. The peptide’s effects are thought to involve immuno‑endocrine cooperation between pineal and thymic tissues, possibly through activation or suppression of specific transcription factors.
What the Research Shows
Animal experiments show that epitalon extends lifespan in rodents and fruit flies, restores circadian melatonin and cortisol rhythms in aged rhesus monkeys, and preserves retinal morphology in hereditary retinitis pigmentosa models. A small human series reported visual improvement in 90 % of patients with retinal degeneration. Reviews describe regulation of aging‑related genes (CCL11, HMGB1), antioxidant and antimutagenic actions, and telomerase activation, but most data are pre‑clinical or from uncontrolled clinical observations. A 2026 gerontology review classifies epitalon as an investigational peptide with promising telomere‑targeting activity yet lacking robust clinical validation.
Reported Benefits
Reported benefits include preservation of retinal function in animal models and patients with degenerative retinal disease, increased melatonin output, modulation of immune markers, antioxidant and anticarcinogenic effects in rodents, and potential activation of telomerase. These outcomes are supported by experimental data and limited clinical observations, though quantitative efficacy evidence remains sparse.
Limitations of the Evidence
Evidence is largely pre‑clinical; human studies are few, uncontrolled, and often lack randomisation or long‑term follow‑up. Conflicting statements on whether epitalon activates or suppresses CCL11/HMGB1 illustrate mechanistic uncertainty. No large‑scale safety or pharmacokinetic trials have been published, and the peptide remains a research compound without regulatory approval.
Safety Considerations
The abstracts do not describe specific adverse events, and systematic safety assessments are absent. Consequently, potential risks are unknown, and caution is warranted. Epitalon is administered experimentally via intravenous, subcutaneous, nasal, or oral routes, but formulations are not standardized for clinical use.
How It Is Administered
In research settings epitalon is delivered intravenously, subcutaneously, nasally, or orally, typically as a sterile aqueous solution of the tetrapeptide. Formulations are experimental, lacking standardization or regulatory approval for therapeutic use.
Routes of Administration
Goals & Uses
- Oncology preventionOncologyLow
- Telomere lengtheningLongevityModerate
- NeuroprotectionNeurologyLow
- Telomere elongationCellular BiologyLow
- Circadian rhythm and sleep normalizationNeuroendocrineLow
- Anti-aging / LongevityAgingLow
- Immune modulationImmunologyLow
Contraindications
- Active malignancyOncologyHighUse caution or avoid depending on agent and context
- Pediatric usePopulationHigh
- PregnancyPopulationModeratePotential fetal risk or insufficient safety data
- BreastfeedingPopulationModeratePotential transfer into breast milk or insufficient safety data
Adverse Effects
- Injection site reactionsLocalCommon
- HeadacheNeurologicUnknownPain in the head or upper neck
- HypotensionCardiovascularRareLow blood pressure
- NauseaGastrointestinalUnknownFeeling of sickness or urge to vomit
- FatigueGeneralUncommonLow energy or tiredness
- Unknown long-term effectsGeneralUnknown
Drug Interactions
- Melatonin / Melatonin agonistsLow
- ImmunosuppressantsModeratePotential interaction with immune pathways or infection risk
- Melatonin agonistsLow
Population Constraints
- Pediatric patientsAgeAbsolute
- ElderlyAgeRelative
- Pregnant or lactating womenReproductiveAbsolute
- Elderly patientsAgeRelative
- Patients with history of cancerOncologyRelative
- ChildrenPediatricRelative
Regulatory Status
- European UnionUnapprovedNo marketing authorization; sold as a laboratory reagent.
- United StatesUnapprovedConsidered a research chemical; not FDA‑approved.
- United KingdomUnapprovedNot licensed for medicinal use.
Not approved by FDA, EMA or MHRA; marketed as a research chemical or dietary supplement in some jurisdictions with limited clinical evidence.
Evidence & Sources
- Journal ArticleModerateKhavinson V, et al.2002-01-01T00:00:00.000000Z
- Journal ArticleModerateKhavinson VKh, et al.2014-01-01T00:00:00.000000Z
- Journal ArticleModerateMavrych V, Shypilova I, Bolgova O2026-01-01T00:00:00.000000Z
- Journal ArticleModerateKhavinson VKh2002-01-01T00:00:00.000000Z
- Journal ArticleModerateAraj SK, et al.2025-01-01T00:00:00.000000Z
- Journal ArticleModerateLin'kova NS, et al.2011-01-01T00:00:00.000000Z
Frequently Asked Questions
What is epitalon and how was it discovered?
Epitalon is a synthetic tetrapeptide (Ala‑Glu‑Asp‑Gly) designed to mimic a component of Epithalamin, a bovine pineal‑gland extract. It was created by isolating the amino‑acid sequence common to pineal and retinal tissues and synthesising the short peptide for experimental study.
Has epitalon been shown to extend human lifespan?
Longevity benefits have been demonstrated in rodents, fruit flies, and aged monkeys, but human data are limited to small, uncontrolled observations. No robust clinical trials have confirmed a lifespan‑extending effect in people.
Is epitalon safe to use in humans?
Published abstracts do not report adverse events, but systematic safety evaluations are lacking. Because comprehensive toxicology and human safety data are absent, the safety profile of epitalon remains uncertain.
How is epitalon administered in research studies?
Researchers have used intravenous, subcutaneous, nasal, and oral routes, typically delivering the peptide in a sterile aqueous solution. Doses and schedules vary across studies and are not standardized.
What conditions might benefit from epitalon?
Pre‑clinical and limited clinical evidence suggests potential benefits for age‑related retinal degeneration, melatonin dysregulation, immune‑endocrine decline, and possibly telomere attrition. These indications remain investigational pending rigorous clinical trials.
What is Epitalon used for?
Epitalon is educationally associated with: Oncology prevention, Telomere lengthening, Neuroprotection, Telomere elongation, Circadian rhythm and sleep normalization, Anti-aging / Longevity, Immune modulation. Educational only — not medical advice.
How is Epitalon administered?
Recorded routes of administration: Intramuscular, Intravenous, Nasal, Oral, Subcutaneous.
What are the potential side effects of Epitalon?
Reported adverse effects include: Injection site reactions, Headache, Hypotension, Nausea, Fatigue, Unknown long-term effects. This list is not exhaustive — consult a qualified clinician.
Who should avoid Epitalon?
Recorded contraindications: Active malignancy, Pediatric use, Pregnancy, Breastfeeding. Consult a qualified clinician before use.